Human medicinehttps://www.ema.europa.eu/en/homepageHuman medicineen-gbCopyright: (C) European Medicines AgencyThu, 02 May 2024 17:20:00 +0200Fri, 02 Feb 2024 15:43:00 +0100Human medicines European public assessment report (EPAR): Bekemv, eculizumab, Date of authorisation: 19/04/2023, Revision: 2, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/bekemvHuman medicines European public assessment report (EPAR): Bekemv, eculizumab, Date of authorisation: 19/04/2023, Revision: 2, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/bekemvFri, 02 Feb 2024 15:43:00 +0100Human medicineBekemv : EPAR - Product Informationhttps://www.ema.europa.eu/system/files/documents/product-information/ema-combined-h-5652_en_1.pdfBekemv : EPAR - Product Informationhttps://www.ema.europa.eu/system/files/documents/product-information/ema-combined-h-5652_en_1.pdfFri, 02 Feb 2024 13:20:00 +0100Human medicine